INTELLIA THERAPEUTICS INC shareholders Q3 2023

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Caption Management, LLC 500$15,8100.00%
SJS Investment Consulting Inc. 27$8550.00%
MASSMUTUAL TRUST CO FSB/ADV 83$2,6240.00%
Allspring Global Investments Holdings, LLC 7,562$239,1100.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 11$3480.00%
Spire Wealth Management 100$3,1620.00%
AMERIPRISE FINANCIAL INC 33,355$1,051,4640.00%
Allworth Financial LP 23$7280.00%
NOMURA ASSET MANAGEMENT CO LTD 0$00.00%
Bartlett & Co. LLC 200$60.00%
Colonial Trust Advisors 75$2,3720.00%
CITIGROUP INC 100$3,1620.00%
CITIGROUP INC 5,000$158,1000.00%
Baystate Wealth Management LLC 93$2,9520.00%
Bell Investment Advisors, Inc 39$1,2340.00%
Bank Julius Baer & Co. Ltd, Zurich 2,598$820.00%
External links

This page lists INTELLIA THERAPEUTICS INC's shareholders in Q3 2023. To view INTELLIA THERAPEUTICS INC's shareholder history, click here.